ISPOR - The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin And Rivaroxaban In The Treatment Of Acute Pulmonary Embolism In The Uk

Full Text

The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin And Rivaroxaban In The Treatment Of Acute Pulmonary Embolism In The Uk

Abstract

Authors

A.V. Jugrin A.V. Ustyugova M. Urbich M. Lamotte T.J. Sunderland

Back to Volume 17, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now